Investigation of the Role of Hemodynamics in Re-stenosis of CABG Patients
1 other identifier
observational
54
1 country
1
Brief Summary
CFD simulations in this study provide detailed hemodynamics information, which cannot be obtained from cardiac images alone. The investigators hypothesize that our proposed simulations will provide strong correlation between hemodynamic parameters, such as WSSG and SPA, and clinically identified graft stenosis. These correlations will allow the investigators to identify the future patients at high risk of graft stenosis and lead to future researches on optimizing and refining surgical plans, such as finding optimal proximal and distal anastomoses locations, optimal graft length and diameter, which could lead to improved longevity of the graft. Once CFD coupled shape optimizer is validated, it could be part of the surgical simulator to help in training the next generation physicians. It could provide new viewpoints for assessing whether some modified surgical techniques are better or not. It could also aid in designing and evaluating the vascular medical devices, including stent, artificial graft, and etc., which would lead to better surgical outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 31, 2016
CompletedFirst Posted
Study publicly available on registry
June 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedJune 7, 2019
September 1, 2017
5.3 years
May 31, 2016
June 6, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Evidence of allergic reaction due to CTA scan contrast
Within first day after scan
Study Arms (2)
Coronary Artery Disease for CABG
Patients undergoing or underwent Coronary Bypass Surgery with at least one saphenous vein graft. Intra-operative graft flow rate measurement will be done during CABG surgery.
Stable/Unstable Angina
Patients with no known history of coronary artery disease undergoing Computed Tomography Angiography scan due to stable/Unstable Angina.
Interventions
The CTA is non-invasive and is used commonly for patients who have chest pain to assess the coronary artery disease, prior to the more invasive coronary angiogram.
This procedure involves the insertion of a Medistim Ultrasound Transit Time Flow Probe into the graft vessel to measure its flow rate. This technique is commonly used for evaluating graft opening during CABG surgery.
Eligibility Criteria
Potential patients scheduled for Coronary Bypass Surgery identified at NHCS cardiology inpatient and patients with stable/unstable angina from cardiology inpatient and outpatient clinic.
You may qualify if:
- Aged 21-80.
- Undergoing or underwent CABG with at least one saphenous vein graft. (Only for recruitment of CABG patients)
- No known history of coronary artery disease (only for recruitment of volunteers with Stable/unstable angina).
You may not qualify if:
- Individuals unable to provide informed consent.
- Non-cardiac illness with life expectancy \<2 years.
- Pregnant state.
- Allergy to iodinated contrast.
- Significant arrhythmia; heart rate ≥ 100 beats/min; systolic blood pressure ≤90 mmHg.
- Renal dysfunction(Glomerular filtration rate (GFR) \<30 mL/min/1.73m2).
- Contraindication to beta blockers or nitroglycerin.
- Canadian Cardiovascular Society class IV angina.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Heart Centre Singapore
Singapore, 169609, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Junmei Zhang
National Heart Centre Singapore
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2016
First Posted
June 6, 2016
Study Start
June 1, 2013
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
June 7, 2019
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share